Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2013

View Archived Issues

Diabetes drug may be useful in treatment of X-linked adrenoleukodystrophy

Fecal metagenome associated with glucose control in a European cohort

A novel GABA(A) receptor agonist PET ligand shows good brain uptake in non-human primates

Curie-Cancer and Sanofi collaboration targets ovarian cancer therapeutics

Celgene presents results for apremilast in psoriatic arthritis and Behcet's syndrome

Silenseed's siG12D LODER evaluated for pancreatic cancer

Diffusion Pharmaceuticals' private financing round to support phase II trial in GBM

DBV Technologies reports data from Viaskin Peanut study

Actelion Pharmaceuticals divulges novel antibacterial agents

Researchers at BIKAM Pharmaceuticals disclose new agents for ophthalmic disorders

Novel CCR4 receptor antagonists prepared by ChemoCentryx

Initiation of clinical trials for IDX-20963 on hold following FDA request

AiCuris patents novel reverse transcriptase inhibitors for HIV infection

Protalix BioTherapeutics profiles three new compounds

Researchers in The Netherlands synthesize novel products

Takeda submits BLA to the FDA for vedolizumab

3-V Biosciences completes financing round for novel fatty acid synthase inhibitor

Amarin reports results from phase I trial of AMR-102

Bionor Pharma obtains GLOBVAC grant to advance research on Vacc-HIV

FDA approves genotyping test for patients with hepatitis C virus

FDA grants breakthrough therapy designation to serelaxin for acute heart failure

Medicago produces plant-based rotavirus vaccine candidate

FDA accepts for review sNDA to expand Xeljanz label

FDA approves Vibativ for hospital-acquired and ventilator-associated bacterial pneumonia

Boehringer Ingelheim seeks EMA approval of Pradaxa for DVT and PE indications

Xtandi approved in Europe for advanced prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...